Charlie's Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Charlie's Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $16.25M | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $26.42M | Apr 15, 2024 |
| FY2020 | Dec 31, 2020 | $16.69M | Apr 5, 2021 |
| FY2020 | Dec 31, 2019 | $22.74M | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $20.84M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $3.82M | Apr 1, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $3.82M | Jun 26, 2018 |
| FY2017 | Dec 31, 2016 | $2.58M | Jun 26, 2018 |
| FY2016 | Dec 31, 2015 | $6.12M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $4.69M | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $2.65M | Apr 2, 2015 |
| FY2013 | Dec 31, 2012 | $1.02M | Mar 31, 2014 |
| FY2011 | Dec 31, 2011 | $1.27M | Apr 6, 2012 |
| FY2011 | Dec 31, 2010 | $2.27M | Apr 6, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.66M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $2.88M | Apr 1, 2026 |
| FY2018 | Dec 31, 2018 | $718.6K | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $771.2K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $321.9K | Jun 26, 2018 |
| FY2016 | Dec 31, 2015 | ($161.0K) | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $291.7K | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $521.8K | Apr 2, 2015 |
| FY2013 | Dec 31, 2012 | $272.4K | Mar 31, 2014 |
| FY2011 | Dec 31, 2011 | $567.6K | Apr 6, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.50M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($4.16M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($2.09M) | May 29, 2025 |
| FY2023 | Dec 31, 2022 | ($1.59M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $4.81M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($7.19M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($2.15M) | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $7.20M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($12.45M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($5.45M) | Jun 26, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.17M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($3.30M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($2.20M) | May 29, 2025 |
| FY2023 | Dec 31, 2022 | ($1.81M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $565.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($6.77M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($5.76M) | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $7.20M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($14.44M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($8.29M) | Jun 26, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $169.0K | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $804.0K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $24.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $3.38M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $1.10M | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $0 | Apr 14, 2020 |
| FY2011 | Dec 31, 2011 | $290 | Apr 6, 2012 |
| FY2011 | Dec 31, 2010 | $13.3K | Apr 6, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.78M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($1.62M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($783.0K) | May 29, 2025 |
| FY2023 | Dec 31, 2022 | ($1.72M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($1.35M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($3.27M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($2.04M) | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $7.62M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($6.43M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($5.67M) | Jun 26, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.0K | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Apr 1, 2026 |
| FY2023 | Dec 31, 2023 | $0 | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $189.0K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $110.0K | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $169.0K | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $571.0K | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $16.0K | Apr 14, 2020 |
| FY2017 | Dec 31, 2017 | $0 | Jun 26, 2018 |
| FY2017 | Dec 31, 2016 | $11.8K | Jun 26, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.56M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $3.95M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $5.77M | May 29, 2025 |
| FY2023 | Dec 31, 2022 | $7.06M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $9.25M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $6.53M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $7.85M | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $2.19M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $4.87M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $4.94M | Jun 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.14M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $5.73M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $5.88M | May 29, 2025 |
| FY2023 | Dec 31, 2022 | $5.36M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $6.12M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | $12.52M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | $8.40M | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.40M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | $10.26M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $7.16M | Jun 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.42M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($1.78M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2023 | ($107.0K) | Apr 1, 2026 |
| FY2024 | Dec 31, 2022 | $1.70M | May 29, 2025 |
| FY2023 | Dec 31, 2021 | $3.13M | Apr 15, 2024 |
| FY2022 | Dec 31, 2020 | ($6.00M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2019 | ($547.0K) | Apr 12, 2022 |
| FY2020 | Dec 31, 2018 | $791.0K | Apr 5, 2021 |
| FY2019 | Dec 31, 2017 | $1.54M | Apr 14, 2020 |
| FY2018 | Dec 31, 2016 | ($2.22M) | Apr 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $1.58M | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $3.47M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.47M | Jun 26, 2018 |
| FY2016 | Dec 31, 2015 | $3.47M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $3.47M | Mar 24, 2016 |
| FY2014 | Dec 31, 2013 | $3.47M | Apr 2, 2015 |
| FY2013 | Dec 31, 2012 | $3.47M | Mar 31, 2014 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($8.20M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($12.70M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($8.54M) | May 29, 2025 |
| FY2023 | Dec 31, 2022 | ($6.45M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($4.86M) | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | ($9.66M) | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | ($2.48M) | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | $649.0K | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | ($48.24M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($35.79M) | Jun 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $43.2K | Apr 1, 2019 |
| FY2018 | Dec 31, 2017 | $76.5K | Apr 1, 2019 |
| FY2018 | Dec 31, 2016 | $224.9K | Apr 1, 2019 |
| FY2017 | Dec 31, 2015 | $376.8K | Jun 26, 2018 |
| FY2016 | Dec 31, 2014 | $668.3K | Mar 31, 2017 |
| FY2015 | Dec 31, 2013 | $3.14M | Mar 24, 2016 |
| FY2014 | Dec 31, 2012 | $4.4K | Apr 2, 2015 |
| FY2011 | Dec 31, 2011 | $26.1K | Apr 6, 2012 |
| FY2011 | Dec 31, 2010 | $41.1K | Apr 6, 2012 |
| FY2011 | Dec 31, 2009 | $45.3K | Apr 6, 2012 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.16M | May 29, 2025 |
| FY2023 | Dec 31, 2023 | $2.46M | Apr 15, 2024 |
| FY2022 | Dec 31, 2022 | $1.45M | Apr 17, 2023 |
| FY2021 | Dec 31, 2021 | $150.0K | Apr 12, 2022 |
| FY2014 | Dec 31, 2014 | $2.00M | Apr 2, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 0 | May 29, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2022 | Dec 30, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 12, 2022 |
| FY2021 | Dec 30, 2020 | 0 | Apr 12, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Apr 14, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 0 | May 29, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Apr 17, 2023 |
| FY2022 | Dec 30, 2021 | 0 | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Apr 12, 2022 |
| FY2021 | Dec 30, 2020 | 0 | Apr 12, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Apr 14, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Apr 14, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 270.65M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 257.29M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 228.54M | May 29, 2025 |
| FY2023 | Dec 31, 2022 | 219.16M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 210.89M | Apr 17, 2023 |
| FY2021 | Dec 31, 2020 | 189.91M | Apr 12, 2022 |
| FY2020 | Dec 31, 2019 | 18.97B | Apr 5, 2021 |
| FY2019 | Dec 31, 2018 | 141.00M | Apr 14, 2020 |
| FY2018 | Dec 31, 2017 | 218.15M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 119.40M | Jun 26, 2018 |